3D Echocardiographic Assessment of Epicardial Pacing After Cardiopulmonary Bypass.

April 11, 2018 updated by: Suzanne Flier, MD

The Hemodynamic Effect of Transient Epicardial Right Ventricular Pacing After Cardiopulmonary Bypass, Assessed by Real-time Three-dimensional Echocardiography.

This study evaluates the usefulness of 3D echocardiography to guide pacemaker therapy in the operating room in cardiac surgical patients. Each patient will serve as his own control, following a paired design.

Study Overview

Detailed Description

Cardiac surgical patients sometimes require temporary pacing wires to optimize cardiac function during weaning from cardiopulmonary bypass (CPB), and/or to treat hemodynamically significant brady-arrhythmias. The available patient series report that 8.6% to 23.9% of patient undergoing coronary artery bypass grafting (CABG) or valve surgery require temporary pacing at some time after CPB. The site of pacemaker wire placement seems to be a crucial determinant of cardiac output. In non-surgical patients isolated right ventricular (RV) pacing seems to induce electromechanical dyssynchrony of the RV and the left ventricle (LV). A normal ventricle in sinus rhythm displays a simultaneous contraction of all segments of the heart, so that regional minimal volume (i.e. maximal contraction) will occur at the same time. Isolated RV pacing seems to result in a left bundle branch type electrical activation sequence, with delayed contraction of some of the segments. The LV, but not the RV, seems to negatively affected by this state of dyssynchrony, resulting in decreased cardiac output. In surgical patients however, there is not such data available yet. Since isolated RV epicardial wire placement is still widely practiced in cardiac surgery, and in our own institution, we would like to study the effect of RV pacing on LV synchrony and LV output.

Again from studies in non-surgical patients receiving resynchronization therapy, we know that real-time three-dimensional (3D) echocardiography is very useful to pick up subtle changes in LV synchrony and thereby guide synchronization of ventricular contraction. However, to date the usefulness of real-time 3D echocardiography to guide pacemaker therapy in cardiac surgery is unknown. In the present feasibility study in cardiac surgical patients, we want to investigate the acute effects of isolated RV pacing on LV synchrony, and LV output.

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ontario
      • London, Ontario, Canada, N6A 5A5
        • University Hospital - London Health Sciences Centre

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Adult patient scheduled to undergo elective cardiac surgery by means of full sternotomy and use of cardiopulmonary bypass
  • Preoperative moderate to good LV function, ejection fraction > 30%
  • Age > 18 yrs. old
  • Preoperative sinus rhythm
  • Pacemaker lead inserted by cardiac surgeon during surgery
  • Underlying sinus rhythm after cardiopulmonary bypass before the end of surgery
  • Able to understand written and verbal patient information
  • Signed informed consent

Exclusion Criteria:

  • Emergency cardiac surgery
  • Minimally invasive surgery
  • Contraindication to TEE
  • Redo surgery
  • Hemodynamic instability after CPB (late exclusion criterium)
  • No pacemaker lead inserted by cardiac surgeon (late exclusion criterium)
  • No sinus rhythm during chest closure towards the end of surgery (late exclusion criterium)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Sham Comparator: Non-paced
  • cardiac surgery
  • 3D TEE measurements of systolic dyssynchrony
  • right ventricular epicardial pacemaker lead (off)
Elective cardiac surgery, with use of cardiopulmonary bypass.
Intraoperatively, all patients will be monitored by means of TEE
Other Names:
  • three-dimensional transesophageal echocardiography
All patients will have a epicardial pacemaker lead in situ.
Experimental: Paced

The patient is randomized to the order of measurements taken, and serves as his own control.

  • cardiac surgery
  • 3D TEE measurements of systolic dyssynchrony
  • right ventricular epicardial pacemaker lead (on)
Elective cardiac surgery, with use of cardiopulmonary bypass.
Intraoperatively, all patients will be monitored by means of TEE
Other Names:
  • three-dimensional transesophageal echocardiography
All patients will have a epicardial pacemaker lead in situ.
The patient's own heart rate at that moment will be the starting point for the study. Right ventricle pacing will be instituted by selecting a rate that is 5 beats above the patient's own heart rate. We will use a stepwise approach where we increase the pacermaker's rate with steps of 5 beats until we have 100% capture of the pacemaker beats. After waiting for at least one minute of pacing we will obtain a set of measurements.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Left ventricular systolic dyssynchrony index (SDI)
Time Frame: Intraoperative, end of cardiac surgery (duration 10 minutes)
For each segment of 16 segments excluding the apical cap in a standard 17-segment model, the time to reach regional minimal volume is calculated as a fraction of the total cardiac cycle (RR interval) and expressed as a percentage.10 The standard deviation of these measurements is defined as the SDI. Three-dimensional SDI is therefore the dispersion time to reach the minimum systolic volume (as recommended).
Intraoperative, end of cardiac surgery (duration 10 minutes)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Ventricular volumes and ejection fraction
Time Frame: Intraoperative, end of cardiac surgery (duration 10 minutes)
We will obtain a full volume 3D dataset and obtain end diastolic (EDV) and end systolic volume (ESV). By subtracting ESV from EDV we will obtain the ejection fraction (EF).
Intraoperative, end of cardiac surgery (duration 10 minutes)
LVOT blood flow
Time Frame: Intraoperative, end of cardiac surgery (duration 10 minutes)
As a surrogate for cardiac output we will obtain the velocity time integral (VTI) across the left ventricular outflow tract (LVOT)
Intraoperative, end of cardiac surgery (duration 10 minutes)
Presence and severity of mitral regurgitation
Time Frame: Intraoperative, end of cardiac surgery (duration 10 minutes)
From midesophageal position we will perform a transesophageal echocardiography (TEE) study to interrogate the mitral valve for the presence and severity of mitral regurgitation.
Intraoperative, end of cardiac surgery (duration 10 minutes)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Suzanne Flier, MD MSc, London Health Sciences Center

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 20, 2017

Primary Completion (Actual)

December 12, 2017

Study Completion (Anticipated)

August 1, 2018

Study Registration Dates

First Submitted

July 20, 2016

First Submitted That Met QC Criteria

July 22, 2016

First Posted (Estimate)

July 25, 2016

Study Record Updates

Last Update Posted (Actual)

April 12, 2018

Last Update Submitted That Met QC Criteria

April 11, 2018

Last Verified

April 1, 2018

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Disorder of Pacing Function

Clinical Trials on cardiac surgery

Subscribe